Liaoning He Eye Hospital Group Co. LTD. (301103) - Total Liabilities

Latest as of June 2026: CN¥290.48 Million CNY ≈ $42.51 Million USD

Based on the latest financial reports, Liaoning He Eye Hospital Group Co. LTD. (301103) has total liabilities worth CN¥290.48 Million CNY (≈ $42.51 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Liaoning He Eye Hospital Group Co. LTD. liquidity resilience to evaluate the company's liquid asset resilience ratio.

Liaoning He Eye Hospital Group Co. LTD. - Total Liabilities Trend (2019–2025)

This chart illustrates how Liaoning He Eye Hospital Group Co. LTD.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Liaoning He Eye Hospital Group Co. LTD. asset portfolio.

Liaoning He Eye Hospital Group Co. LTD. Competitors by Total Liabilities

The table below lists competitors of Liaoning He Eye Hospital Group Co. LTD. ranked by their total liabilities.

Company Country Total Liabilities
D-Link Corp
TW:2332
Taiwan NT$5.07 Billion
Lingsen Precision Industries Ltd
TW:2369
Taiwan NT$2.59 Billion
Chemclin Diagnostics Co. Ltd. A
SHG:688468
China CN¥344.10 Million
Shaanxi Meibang Pharmaceutical Group Co Ltd
SHG:605033
China CN¥757.69 Million
KNOT Offshore Partners LP
NYSE:KNOP
USA $1.04 Billion
CASIN Real Estate Development Group Co Ltd
SHE:000838
China CN¥2.14 Billion
EGing Photovoltaic Technology Co Ltd
SHG:600537
China CN¥4.06 Billion
Agro Tech Foods Limited
NSE:ATFL
India Rs1.33 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Liaoning He Eye Hospital Group Co. LTD.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 301103 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 9.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.13 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Liaoning He Eye Hospital Group Co. LTD.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Liaoning He Eye Hospital Group Co. LTD. (2019–2025)

The table below shows the annual total liabilities of Liaoning He Eye Hospital Group Co. LTD. from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥297.47 Million
≈ $43.53 Million
-13.95%
2024-12-31 CN¥345.71 Million
≈ $50.59 Million
-15.96%
2023-12-31 CN¥411.36 Million
≈ $60.19 Million
-4.39%
2022-12-31 CN¥430.24 Million
≈ $62.96 Million
+15.82%
2021-12-31 CN¥371.48 Million
≈ $54.36 Million
-4.19%
2020-12-31 CN¥387.72 Million
≈ $56.73 Million
+203.69%
2019-12-31 CN¥127.67 Million
≈ $18.68 Million
--

About Liaoning He Eye Hospital Group Co. LTD.

SHE:301103 China Medical Care Facilities
Market Cap
$365.59 Million
CN¥2.50 Billion CNY
Market Cap Rank
#13988 Global
#4192 in China
Share Price
CN¥15.81
Change (1 day)
+0.64%
52-Week Range
CN¥14.65 - CN¥22.39
All Time High
CN¥46.13
About

Liaoning He Eye Hospital Group Co., LTD., together with its subsidiaries, provides ophthalmological and optometry services to patients with eye diseases in China. The company offers treatment for common blinding eye diseases, including cataracts, glaucoma, and vitreoretinal disorders; specialized treatments, such as dry eye and traditional Chinese medicine; and optometry services, including optic… Read more